EPISPRAY Trademark

Trademark Overview

On Tuesday, August 24, 2021, a trademark application was filed for EPISPRAY with the United States Patent and Trademark Office. The USPTO has given the EPISPRAY trademark a serial number of 90899911. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Thursday, October 16, 2025. This trademark is owned by MiMedX Group, Inc.. The EPISPRAY trademark is filed in the Pharmaceutical Products category with the following description:

Liquid suspension of growth factors and specialty proteins in the nature of non-viable epithelial cells derived from placental tissues intended for use in the treatment of dermal abrasions
epispray

General Information

Serial Number90899911
Word MarkEPISPRAY
Filing DateTuesday, August 24, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateThursday, October 16, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 25, 2022

Trademark Statements

Goods and ServicesLiquid suspension of growth factors and specialty proteins in the nature of non-viable epithelial cells derived from placental tissues intended for use in the treatment of dermal abrasions

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, October 10, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMiMedX Group, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMarietta, GA 30062
Party NameMiMedX Group, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMarietta, GA 30062

Trademark Events

Event DateEvent Description
Friday, August 27, 2021NEW APPLICATION ENTERED
Sunday, October 10, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 26, 2022ASSIGNED TO EXAMINER
Wednesday, June 8, 2022NON-FINAL ACTION WRITTEN
Wednesday, June 8, 2022NON-FINAL ACTION E-MAILED
Wednesday, June 8, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, September 16, 2022EXAMINERS AMENDMENT -WRITTEN
Friday, September 16, 2022EXAMINERS AMENDMENT E-MAILED
Friday, September 16, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, September 16, 2022EXAMINER'S AMENDMENT ENTERED
Friday, September 16, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 5, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 25, 2022PUBLISHED FOR OPPOSITION
Tuesday, October 25, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 20, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 20, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, June 20, 2023SOU EXTENSION 1 FILED
Tuesday, June 20, 2023SOU EXTENSION 1 GRANTED
Thursday, June 22, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 15, 2023SOU TEAS EXTENSION RECEIVED
Friday, December 15, 2023SOU EXTENSION 2 FILED
Friday, December 15, 2023SOU EXTENSION 2 GRANTED
Tuesday, December 19, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 26, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, March 26, 2024SOU EXTENSION 3 FILED
Tuesday, March 26, 2024SOU EXTENSION 3 GRANTED
Wednesday, March 27, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 3, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, December 3, 2024SOU EXTENSION 4 FILED
Tuesday, December 17, 2024SOU EXTENSION 4 GRANTED
Tuesday, December 17, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 16, 2025ABANDONMENT - NO USE STATEMENT FILED
Thursday, October 16, 2025ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

epispray placental from derived tissues intended abrasions dermal treatment cells epithelial